These Healthcare stocks are trading higher:
-Biofrontera (BFRIW) stock is trading at $6.90, a rise of $3.87, or 127.72%, on high volume. Biofrontera Inc WT gets a Sentiment Score of Neutral from InvestorsObserver.
-Biofrontera Inc (BFRI) stock is trading at $12.25, an increase of $4.61, or 58.27%, on high volume. Biofrontera Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $15.50.
-Oncology Pharma Inc (ONPH) stock is trading at $5.76, an increase of $1.62, or 39.13%, on high volume. Oncology Pharma Inc gets a Sentiment Score of Very Bullish from InvestorsObserver.
-IsoPlexis Corp (ISO) stock is trading at $6.80, an increase of $1.9, or 38.27%, on high volume. Isoplexis Corp gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $20.33.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Aldeyra Therapeutics Inc (ALDX) stock is trading at $3.55, a drop of $3.58, or 50.28%, on high volume. Aldeyra Therapeu gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $22.50.-DBV Technologies ADR Representing 0.5 Ord Shs (DBVT) stock is trading at $1.47, a drop of $1.23, or 45.19%, on high volume. Dbv Technologies ADR gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $8.00.
-CytomX Therapeutics Inc (CTMX) stock is trading at $3.85, a decline of $2.6, or 40.39%, on high volume. Cytomx Thera gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $13.14.
-Can Fite Biopharma ADR Representing 30 Ord Shs (CANF) stock is trading at $1.40, a decline of $0.75, or 34.88%, on high volume. Can-Fite Biopharma Ltd ADR gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.00.